from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0079/-

LFCtreatmentdescriptionclass of inhibitor

-0.146

Amikacinug/mL Amikacintranslation

-0.206

Cap5-10ug/mL Capreomycintranslation

-0.200

Rox10-50 ug/mL Roxithromycintranslation

-0.184

SM2-5 ug/mL Streptomycintranslation

-0.564

Tet5-10 ug/mL Tetracyclinetranslation

-0.313

Rif0.2-5ug/mL Rifampicintranscription

0.616

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.791

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.014

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.003

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.052

Clofazimine10-13 ug/mL Clofaziminerespiration

0.329

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.212

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.383

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.549

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.721

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.641

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.327

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.734

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.160

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.192

KCN5-20 ug/mL Potassium cyaniderespiration

-0.031

NaN30.2-2 mM Sodium aziderespiration

-0.602

Nigericin50 uM Nigericinrespiration

-0.246

TRC10-150 ug/mL Triclosanrespiration

-0.137

TRZ10-25 ug/mL Thioridazinerespiration

-0.571

Valinomycin0.5-10 uM Valinomycinrespiration

-0.431

ZnSO42 mM ZnSO4respiration

0.039

menadione6-10 ug/mL Menadionerespiration

0.175

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.347

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.229

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.766

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

4.249

NRP_1Non-replicating persistence stage 1dosRassociated

-0.482

Amp0.2mg/mL AmpicillincellWall

-0.268

Cephalexin20-100 ug/mL CephalexincellWall

-0.196

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.497

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.500

EMB10-20 ug/mL EthambutolcellWall

-0.251

Eta12-40 ug/mL EthionamidecellWall

-0.296

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.029

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.656

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.145

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.071

BZA0.12 mg/mL BenzamidearomaticAmides

-0.119

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.306

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.880

H2O24 mM hydrogen peroxideDNAdamaging

0.182

Levo10 ug/mL LevofloxacinDNAdamaging

-0.566

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.049

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.049

UVUV-irradiationDNAdamaging

0.613

ARP41-4 ug/mL Antitubercular compound ARP4?

0.206

Antimycin12.5-50 ug/mL Antimycin A?

0.031

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.190

PA_110-50 ug/mL Antitubercular compound PA-1?

0.041

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.998

PA8240.2-2 ug/mL PA-824?

2.030

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.124

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.082

Verapamil50 uM Verapamil?

0.181

mercaptoethanol2 mM 2-Mercaptoethanol?

0.054

methoxatin10-20 ug/mL Methoxatin?